[Federal Register Volume 61, Number 245 (Thursday, December 19, 1996)]
[Notices]
[Page 66999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32208]


-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Notice of Intent to Grant Exclusive Patent License; SmithKline 
Beecham Biologicals S.A.

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to SmithKline Beecham Biologicals S.A., a revocable, 
nonassignable, exclusive license in the United States to practice the 
Government owned invention described in U.S. Patent No. 5,198,535 
entitled ``Protective Malaria Sporozoite Surface Protein Immunogen and 
Gene,'' issued March 30, 1993 in the field of human vaccines to prevent 
and/or treat malaria based on proteins, polypeptides and/or peptides.
    Anyone wishing to object to the grant of this license has 60 days 
from the date of this notice to file written objections along with 
supporting evidence, if any. Written objections are to be filed with 
the Office of Naval Research, ONR 00CC, Ballston Tower One, 800 North 
Quincy Street, Arlington, Virginia 22217-5660.

FOR FURTHER INFORMATION CONTACT: Mr. R. J. Erickson, Staff Patent 
Attorney, Office of Naval Research, ONR 00CC, Ballston Tower One, 800 
North Quincy Street, Arlington, Virginia 22217-5660, telephone (703) 
696-4001.

    Dated: December 10, 1996.
D.E. Koenig,
LCDR, JAGC, USN, Federal Register Liaison Officer.
[FR Doc. 96-32208 Filed 12-18-96; 8:45 am]
BILLING CODE 3810-FF-P